Khobar, Saudi Arabia – July 24, 2025 – Zahrawi Group is proud to announce the signing of a strategic partnership with Rameem Medical Company, marking a significant step forward in expanding and enhancing Trauma care solutions across the Kingdom of Saudi Arabia.

This collaboration brings together Zahrawi Group’s deep expertise in surgical and medical device distribution with Rameem’s specialized capabilities in developing localized healthcare solutions. Zahrawi will act as the exclusive distributor for Rameem’s Trauma portfolio, introducing a focused set of high-quality, locally manufactured products, with plans for continuous expansion over the coming years.

On July 24th, Zahrawi Group’s leadership management and Surgical Division, including Mr. Abdulrahman Ramadan, Group CEO; Mr. Youssef Afifi, Senior Group Finance Director; Mr. Majed El Edrissi, Senior Group Director – Surgical & Cardiovascular; Mr. Ahmed Attiya, Senior Group Supply Chain Director; and Mr. Mohamed Saad, Regional Division Manager – Orthospine (Zahrawi Gulf), met with Dr. Nayef bin Dajim, Chairman of the Board & CEO of Rameem, Dr. Ali Al-Bakry, Business Development Director, and Mr. Jehad bn Dajim, Managing Director, at Rameem’s headquarters in Khobar. Rameem’s top management and team were also present at the event. This meeting laid the groundwork for a strong collaboration, based on shared values, mutual trust, and a common vision for transforming Trauma care in Saudi Arabia.

The discussions were followed by a formal signing ceremony and dinner at the VOCO Hotel, where both organizations presented their long-term visions and discussed the strategic direction of the partnership. The event reaffirmed the commitment of both parties to support healthcare professionals across the Kingdom with advanced, locally relevant solutions.

Rameem Medical Company, a Saudi-based healthcare manufacturer, plays a critical role in advancing the Kingdom’s medical sector. The company has world-class manufacturing units established within Saudi Arabia and serves customers both locally and globally. This partnership underscores Zahrawi Group’s strong commitment to supporting local industry leaders, in alignment with Saudi Arabia’s Vision 2030, which emphasizes the importance of local manufacturing, innovation, and self-sufficiency in the healthcare sector.

While the initial phase of the partnership focuses on select Trauma-related products, both Zahrawi Group and Rameem have outlined a clear path for expanding the portfolio and scaling the impact of their collaboration across the Kingdom.

About Zahrawi Group:

Established in 1989, Zahrawi Group is a pioneer medical devices and life science distributor in the Gulf region, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Zahrawi Group is specialized in surgical, cardiovascular, medical, nuclear medicine, diagnostic, and analytical lab solutions, and was founded with a vision to be the leading and most trusted partner in the GCC.

Zahrawi Group is committed to improving people’s lives by introducing innovative healthcare products, smart solutions, and outstanding services.

To learn more, visit zahrawigroup.com and connect on X (Twitter), LinkedIn, Facebook, Instagram, and Youtube.

About Rameem Medical Company:

Rameem Medical Co. is an integrated, research based, orthopaedic implants manufacturing company, producing a wide range of high quality implants, trusted by healthcare professionals, medical providers, and health bodies across geographies. The company has world-class manufacturing units established in the Kingdom of Saudi Arabia and serves customers locally and globally.

In July 2025, Zahrawi Group convened its leadership teams for two essential Business Review Meetings, held on the 23rd for the Kingdom of Saudi Arabia and on the 28th for the Gulf region. The BRMs served as a critical platform to reinforce transparency, accountability, and cross-functional collaboration, ensuring all teams remain focused on delivering Zahrawi’s strategic objectives through the third quarter and beyond.

The meetings provided a comprehensive review of the company’s ongoing initiatives and emphasized the importance of maintaining momentum in business development and operational excellence. Success stories were highlighted to encourage best practices, while challenges were openly addressed with a solutions-driven approach, reflecting Zahrawi’s commitment to continuous improvement.

At both sessions, Zahrawi Group’s CEO delivered a clear and inspiring message stressing the need to sustain focus throughout Q3 and the remainder of 2025. He encouraged the teams to continue driving business development, pursue operational excellence, and optimize internal processes.

The CEO also underscored the importance of agility, flexibility, and collaboration as key factors for adapting to an evolving healthcare market. He encouraged the teams to continuously seek improvements, product diversity, embrace innovation, and maintain a positive and proactive mindset, while emphasizing his full confidence in their growing expertise and capabilities.

These meetings set a clear direction and renewed energy to propel Zahrawi Group towards successful 2025 closure.

Copyright Al-Zahrawi Medical Supplies Est 2019 All rights reserved

Website by: Zahrawi Group